National Health Investors (NYSE:NHI) Posts Earnings Results, Beats Estimates By $0.31 EPS

National Health Investors (NYSE:NHI) posted its earnings results on Monday. The real estate investment trust reported $1.15 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.31, FiscalAI reports. The firm had revenue of $121.32 million during the quarter, compared to analyst estimates of $72.12 million. National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.

National Health Investors Stock Performance

Shares of NHI stock traded down $1.07 during trading hours on Monday, reaching $74.23. 297,801 shares of the company’s stock were exchanged, compared to its average volume of 435,157. National Health Investors has a fifty-two week low of $67.94 and a fifty-two week high of $91.38. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $3.60 billion, a P/E ratio of 23.95, a P/E/G ratio of 3.38 and a beta of 0.51. The business has a fifty day moving average price of $75.13 and a 200-day moving average price of $79.60.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. BMO Capital Markets dropped their price target on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday, June 15th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research note on Thursday, June 25th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $94.00 target price on shares of National Health Investors in a report on Wednesday, April 22nd. Truist Financial cut their target price on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research report on Friday, June 12th. Finally, Zacks Research cut shares of National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Five analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, National Health Investors has a consensus rating of “Moderate Buy” and an average price target of $83.86.

Insiders Place Their Bets

In related news, Director Robert A. Mccabe, Jr. purchased 890 shares of the firm’s stock in a transaction on Monday, June 15th. The shares were bought at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the transaction, the director directly owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO D. Eric Mendelsohn acquired 1,500 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were bought at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the acquisition, the chief executive officer owned 133,316 shares in the company, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 2.70% of the company’s stock.

Institutional Investors Weigh In On National Health Investors

A number of institutional investors have recently added to or reduced their stakes in NHI. Renaissance Group LLC grew its holdings in shares of National Health Investors by 3.8% in the 4th quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock valued at $245,000 after acquiring an additional 117 shares in the last quarter. Captrust Financial Advisors raised its holdings in National Health Investors by 1.7% during the fourth quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust’s stock worth $680,000 after acquiring an additional 146 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in National Health Investors by 0.8% during the second quarter. The Manufacturers Life Insurance Company now owns 24,603 shares of the real estate investment trust’s stock valued at $1,725,000 after purchasing an additional 200 shares during the last quarter. Mackenzie Financial Corp grew its stake in National Health Investors by 6.7% in the third quarter. Mackenzie Financial Corp now owns 3,201 shares of the real estate investment trust’s stock valued at $254,000 after purchasing an additional 200 shares in the last quarter. Finally, Guggenheim Capital LLC grew its stake in shares of National Health Investors by 1.7% in the second quarter. Guggenheim Capital LLC now owns 13,579 shares of the real estate investment trust’s stock valued at $952,000 after buying an additional 223 shares in the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.